These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17519253)

  • 1. Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends.
    Takahashi T; Tada M; Igarashi S; Koyama A; Date H; Yokoseki A; Shiga A; Yoshida Y; Tsuji S; Nishizawa M; Onodera O
    Nucleic Acids Res; 2007; 35(11):3797-809. PubMed ID: 17519253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanism for spinocerebellar ataxias].
    Onodera O
    Rinsho Shinkeigaku; 2009 Nov; 49(11):750-2. PubMed ID: 20030201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia/ataxia with oculomotor apraxia 1.
    Tada M; Yokoseki A; Sato T; Makifuchi T; Onodera O
    Adv Exp Med Biol; 2010; 685():21-33. PubMed ID: 20687492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-patch single-strand break repair in ataxia oculomotor apraxia-1.
    Reynolds JJ; El-Khamisy SF; Caldecott KW
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):577-81. PubMed ID: 19442253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanism for spinocerebellar ataxias].
    Onodera O
    Rinsho Shinkeigaku; 2009 Jan; 49(1):1-8. PubMed ID: 19227889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA single-strand break repair is impaired in aprataxin-related ataxia.
    Hirano M; Yamamoto A; Mori T; Lan L; Iwamoto TA; Aoki M; Shimada K; Furiya Y; Kariya S; Asai H; Yasui A; Nishiwaki T; Imoto K; Kobayashi N; Kiriyama T; Nagata T; Konishi N; Itoyama Y; Ueno S
    Ann Neurol; 2007 Feb; 61(2):162-74. PubMed ID: 17315206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein.
    Sano Y; Date H; Igarashi S; Onodera O; Oyake M; Takahashi T; Hayashi S; Morimatsu M; Takahashi H; Makifuchi T; Fukuhara N; Tsuji S
    Ann Neurol; 2004 Feb; 55(2):241-9. PubMed ID: 14755728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprataxin, a novel protein that protects against genotoxic stress.
    Gueven N; Becherel OJ; Kijas AW; Chen P; Howe O; Rudolph JH; Gatti R; Date H; Onodera O; Taucher-Scholz G; Lavin MF
    Hum Mol Genet; 2004 May; 13(10):1081-93. PubMed ID: 15044383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.
    Moreira MC; Barbot C; Tachi N; Kozuka N; Uchida E; Gibson T; Mendonça P; Costa M; Barros J; Yanagisawa T; Watanabe M; Ikeda Y; Aoki M; Nagata T; Coutinho P; Sequeiros J; Koenig M
    Nat Genet; 2001 Oct; 29(2):189-93. PubMed ID: 11586300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel nonsense mutation in the APTX gene associated with delayed DNA single-strand break removal fails to enhance sensitivity to different genotoxic agents.
    Crimella C; Cantoni O; Guidarelli A; Vantaggiato C; Martinuzzi A; Fiorani M; Azzolini C; Orso G; Bresolin N; Bassi MT
    Hum Mutat; 2011 Apr; 32(4):E2118-33. PubMed ID: 21412945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological abnormalities in patients with early-onset ataxia with ocular motor apraxia and hypoalbuminemia.
    Kato T; Tamura Y; Matsumoto H; Kobayashi O; Ishiguro H; Ogawa M; Tsujikawa K; Hasegawa Y; Sakamoto M; Konagaya M; Houzen H; Takagi M; Imai K; Morio T; Yokoseki A; Onodera O; Nonoyama S
    Clin Immunol; 2021 Aug; 229():108776. PubMed ID: 34118401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective DNA ligation during short-patch single-strand break repair in ataxia oculomotor apraxia 1.
    Reynolds JJ; El-Khamisy SF; Katyal S; Clements P; McKinnon PJ; Caldecott KW
    Mol Cell Biol; 2009 Mar; 29(5):1354-62. PubMed ID: 19103743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates.
    Ahel I; Rass U; El-Khamisy SF; Katyal S; Clements PM; McKinnon PJ; Caldecott KW; West SC
    Nature; 2006 Oct; 443(7112):713-6. PubMed ID: 16964241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4.
    Clements PM; Breslin C; Deeks ED; Byrd PJ; Ju L; Bieganowski P; Brenner C; Moreira MC; Taylor AM; Caldecott KW
    DNA Repair (Amst); 2004 Nov; 3(11):1493-502. PubMed ID: 15380105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations.
    Shimazaki H; Takiyama Y; Sakoe K; Ikeguchi K; Niijima K; Kaneko J; Namekawa M; Ogawa T; Date H; Tsuji S; Nakano I; Nishizawa M
    Neurology; 2002 Aug; 59(4):590-5. PubMed ID: 12196655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin.
    El-Khamisy SF; Katyal S; Patel P; Ju L; McKinnon PJ; Caldecott KW
    DNA Repair (Amst); 2009 Jun; 8(6):760-6. PubMed ID: 19303373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel splice variants increase molecular diversity of aprataxin, the gene responsible for early-onset ataxia with ocular motor apraxia and hypoalbuminemia.
    Hirano M; Nishiwaki T; Kariya S; Furiya Y; Kawahara M; Ueno S
    Neurosci Lett; 2004 Aug; 366(2):120-5. PubMed ID: 15276230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease.
    Tumbale P; Appel CD; Kraehenbuehl R; Robertson PD; Williams JS; Krahn J; Ahel I; Williams RS
    Nat Struct Mol Biol; 2011 Oct; 18(11):1189-95. PubMed ID: 21984210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA repair and neurodegeneration].
    Onodera O
    Rinsho Shinkeigaku; 2005 Nov; 45(11):979-81. PubMed ID: 16447779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FHA domain of aprataxin interacts with the C-terminal region of XRCC1.
    Date H; Igarashi S; Sano Y; Takahashi T; Takahashi T; Takano H; Tsuji S; Nishizawa M; Onodera O
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1279-85. PubMed ID: 15555565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.